Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression
Titel:
Bicalutamide (Casodex) 150 mg as immediate therapy in patients with localized or locally advanced prostate cancer significantly reduces the risk of disease progression
Auteur:
Wirth, M Tyrrell, C Wallace, M Delaere, K.P Sánchez-Chapado, M Ramon, J Hetherington, J Pina, F Heynes, C.F Borchers, T.M Morris, T Stone, A